Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
While investors obsess over AI, weight-loss drugs like GLP-1 are raking in more revenue, reshaping consumer sectors. Are these drugs the real disruptors?